Reader Question:Do you think it is too late to invest in the players involved in developing vaccines for Covid-19? If not, is it better to go with the large companies or the smaller upstarts?I think there are two angles here. First, Covid itself. I doubt anyone really knows whether these vaccines will be effective enough to get rid of Covid (for the most part) within a year or two, or if we are dealing with a new virus that is constantly mutating and here to stay, in which case annual Covid shots are probably in our future. Since the experts would probably punt on this question, I will too. It sure seems too early to rule out annual shots that would likely be solid moneymakers … [Read More...]
Coronavirus dashboard for April 26: reasons for optimism all around
Coronavirus dashboard for April 26: reasons for optimism all around Let’s start with an overview of total cases and deaths in the US: 1.7 in every 1,000 Americans has died of COVID-19. 9.7% of the entire population has had a *confirmed* infection. Probably another 5% to 10% have been infected, but were never tested. With […] The post Coronavirus dashboard for April 26: reasons for optimism all around appeared first on Angry Bear. [Read More...]
Coronavirus dashboard for April 19: Much great progress, and some problem children
Coronavirus dashboard for April 19: Much great progress, and some problem children ; As an initial note, there is no significant economic data until Thursday this week, so don’t be surprised if I play hooky for a day or two…. Today let’s take a look at the latest coronavirus information. There’s much progress on the […] The post Coronavirus dashboard for April 19: Much great progress, and some problem children appeared first on Angry Bear. [Read More...]